A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

Reshma Mahtani

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Supportive Care in Cancer
Volume	30
State	Published - Jul 1 2022

Cite this

@article{0ff9eca21cee4576b71670dcf9b01a60,

title = "A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis",

author = "Reshma Mahtani",

note = "Supportive Care in Cancer (2022) 30(7):6135-6144",

year = "2022",

month = jul,

day = "1",

language = "American English",

volume = "30",

journal = "Supportive Care in Cancer",

}

TY - JOUR

T1 - A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

AU - Mahtani, Reshma

N1 - Supportive Care in Cancer (2022) 30(7):6135-6144

PY - 2022/7/1

Y1 - 2022/7/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4406

M3 - Article

VL - 30

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

ER -

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

Other files and links

Cite this